Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed-dose vs concentration-controlled CellCept regimens after kidney transplantation
2016-001043-39Phase 4
- Sponsor
- Roche
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate mofetil in kidney transplant immunosuppression, kidney transplant, sponsored by Roche.
02
Drugs
mycophenolate mofetil
03
Conditions
kidney transplant immunosuppressionkidney transplant
Beyond the preview
Go deeper on 2016-001043-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001043-39.